Survival and mortality of people infected with HIV in low and middle income countries: Results from the extended ALPHA network

AIDS

Volumn 21, Issue SUPPL. 6, 2007, Pages

  Ghys, Peter D ^a   Zaba, Basia ^b,c   Prins, Maria ^d,e  

^a UNAIDS   (Switzerland)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^d DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

AFRICA; CENSORSHIP; CONFERENCE PAPER; DEVELOPING COUNTRY; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOWEST INCOME GROUP; MEDICAL RESEARCH; MORTALITY; PRIORITY JOURNAL; SEROCONVERSION; SURVIVAL; ZIMBABWE;

ADULT; AFRICA; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; DEVELOPING COUNTRIES; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; SURVIVAL ANALYSIS;

EID: 36349004703     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000299404.99033.bf     Document Type: Conference Paper

References (29)

1. ALPHA (Analysing Longitudinal Population-based HIV/AIDS data on Africa) network. Available at: www.lshtm.ac.uk/cps/alpha. Accessed: 2 September 2007.
2. World Health Organization, UNAIDS, UNICEF. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report. April 2007. Geneva: WHO; 2007. ISBN 978 92 4 159539 1.
3. Isingo R, Zaba B, Marston M, Ndege M, Mngara J, Mwita W, et al. Survival after HIV infection in the pre-ART era in a rural Tanzanian cohort. AIDS 2007; 21 (Suppl. 6):S5-S13.
4. Lutalo T, Gray RH, Wawer M, Sewankambo N, Serwadda D, Laeyendecker O, et al. Survival of HIV infected treatment-naive persons with documented dates of seroconversion in Rakai, Uganda. AIDS 2007; 21 (Suppl. 6):S15-S19.
5. Van der Paal L, Shafer LA, Todd J, Mayanja BN, Whitworth JAG, Grosskurth H. HIV-1 disease progression and mortality before the introduction of highly active antiretroviral therapy in rural Uganda. AIDS 2007; 21 (Suppl. 6):S21-S29.
6. Peters PJ, Meinzen-Derr J, Karita E, Kayitenkore K, Kim D-J, Tichacek A, Allen SA, for the Rwanda Zambia HIV Research Group. HIV-infected Rwandan women have a high frequency of long-term survival. AIDS 2007; 21 (Suppl. 6):S31-S37.
7. Rangsin R, Piyaraj P, Sirisanthana T, Sirisopana N, Short O, Nelson KE. The natural history of HIV-1 subtype E infection in young men in Thailand with up to 14 years of follow-up. AIDS 2007; 21 (Suppl. 6):S39-S46.
8. Nelson KE, Costello C, Suriyanon V, Sennun S, Duerr A. Survival of blood donors and their spouses with HIV-1 subtype E (CRF01 A_E) infection in northern Thailand, 1992-2007. AIDS 2007; 21 (Suppl. 6):S47-S54.
9. Todd J, Glynn JR, Marston M, Lutalo T, Biraro S, Mwita W, et al. Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy. AIDS 2007; 21 (Suppl. 6):S55-S63.
10. Marston M, Todd J, Glynn JR, Nelson K, Rangsin R, Lutalo T, et al. Estimating "net" HIV-related mortality and the importance of background mortality rates. AIDS 2007; 21 (Suppl. S):S65-S71.
11. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Lancet 2000; 355:1131-1137.
12. Nyirenda M, Hosegood V, Barnighausen T, Newell M-L. Mortality levels and trends by HIV serostatus in rural South Africa. AIDS 2007; 21 (Suppl. 6):S73-S79.
13. Smith J, Mushati P, Kurwa F, Mason P, Gregson S, Lopman B. Changing patterns of adult mortality as the HIV epidemic matures in Manicaland, Zimbabwe. AIDS 2007; 21 (Suppl. 6): S81-S86.
14. Zaba B, Marston M, Crampin A, Isingo R, Biraro S, Bärninghausen T, et al. Age-specific mortality patterns in HIV infected individuals: a comparative analysis of African community study data. AIDS 2007; 21 (Suppl. 6):S87-S96.
15. Murray J, Sonnenberg P, Nelson G, Bester A, Shearer S, Glynn JR. Cause of death and presence of respiratory disease at autopsy in an HIV-1 seroconversion cohort of southern African gold miners. AIDS 2007; 21 (Suppl. 6):S97-S104.
16. McGrath N, Kranzer K, Saul J, Crampin AC, Malema S, Kachiwanda L, et al. Estimating the need for antiretroviral treatment and an assessment of a simplified HIV/AIDS case definition in rural Malawi. AIDS 2007; 21 (Suppl. 6):S105-S113.
17. Auvert B, Males S, Puren A, Taljaard D, Caraël M, Williams B. Can highly active antiretroviral therapy reduce the spread of HIV? A Study in a Township of South Africa. J Acquir Immune Defic Syndr 2004; 36:613-621.
18. Boerma JT, Stanecki KA, Newell M-L, Luo C, Beusenberg M, Garnett GP, et al. Monitoring progress towards 3 by 5. Methods and mid 2005 update. Bull WHO 2006; 84:145-150.
19. The Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration and ART Cohort Collaboration (ART-CC) groups. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006; 367:817-824.
20. Baeten JM, Chohan B, Lavreys L, Chohan V, McClelland RS, Certain L, et al. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis 2007; 195:1177-1180.
21. Senkaali D, Muwonge R, Morgan D, Yirrell D, Whitworth J, Kaleebu P. The relationship between HIV type 1 disease progression and V3 serotype in a rural Ugandan cohort. AIDS Res Hum Retroviruses 2004; 20:932-937.
22. Vasan A, Renjifo B, Hertzmark E, Chaplin B, Msamanga G, Essex M, et al. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin Infect Dis 2006; 42:843-852.
23. Hemelaar J, Gouws E, Ghys PD, Osmanov S, and the UNAIDS/ WHO Network for HIV Isolation and Characterization. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 2006; 20:W13-W23.
24. The UNAIDS Reference Group on Estimates, Modeling and Projections. Improved methods and assumptions for the estimation of the HIV/AIDS epidemic and its impact: recommendations of the UNAIDS Reference Group on Estimates, Modeling and Projections. AIDS 2002; 16:W1-W16.
25. Improving parameter estimation, projection methods, uncertainty estimation, and epidemic classification. Report of a meeting of the UNAIDS Reference Group on Estimates, Modelling and Projections, Prague, Czech Republic, 29 November-1 December 2006. Available at: www.epidem.org/Publications/ Prague2006report.pdf. Accessed: 2 September 2007.
26. Stover J, Walker N, Grassly NC, Marston M. Projecting the demographic impact of AIDS and the number of people in need of treatment: updates to the Spectrum projection package. Sex Transm Infect 2006; 82 (Suppl. III):iii45-iii50.
27. UNAIDS/WHO. AIDS epidemic update, 2007. Geneva: UNAIDS; 2007.
28. Law CG, Brookmeyer R. Effects of mid-point imputation on the analysis of doubly censored data. Stat Med 1992; 11:1569-1578.
29. Clayton D, Hills M. Competing risks and selection. Chapter 7. In: Statistical models in epidemiology. Oxford: Oxford University Press; 1993.